Novartis buys US gene therapy group AveXis for $8.7bn via @FT
https://t.co/C7l5AeqVoI— The Propell Group (@ThePropellGroup) April 9, 2018
Novartis buys US gene therapy group AveXis for $8.7bn via @FT
https://t.co/C7l5AeqVoI— The Propell Group (@ThePropellGroup) April 9, 2018